Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin

Microbial Pathogenesis

Volumn 49, Issue 4, 2010, Pages 141-152

  Higashi, Nobutaka ^a   Matsumura, Youko ^a   Mizuno, Fumiko ^a   Kasahara, Kazuki ^a   Sugiura, Shigeki ^a   Mikasa, Keiichi ^a   Kita, Eiji ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABCA1; Cholesterol efflux; Gb3; Phosphodiesterase inhibitor; Shiga toxin; Vascular endothelial cells

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CELL SURFACE RECEPTOR; CHOLESTEROL; GLOBOTRIAOSYLCERAMIDE; ROLIPRAM; SHIGA TOXIN; SMALL INTERFERING RNA;

ARTICLE; CELL DAMAGE; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; VASCULAR ENDOTHELIUM;

APOLIPOPROTEIN A-I; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; CELLS, CULTURED; CHOLESTEROL; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE MICRODOMAINS; PHOSPHODIESTERASE INHIBITORS; RNA, SMALL INTERFERING; ROLIPRAM; SHIGA TOXIN; TRIHEXOSYLCERAMIDES;

EID: 77955274853     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.05.005     Document Type: Article

References (45)

1. Lynn R.M., O'Brien S.J., Taylor C.M., Adak G.K., Chart H., Cheasty T., et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005, 11:590-596.
2. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998, 11:142-201.
3. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985, 151:775-782.
4. van Setten P.A., Monnens L.A., Verstraten R.G., van den Heuvel L.P., van Hinsbergh V.W. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 1996, 88:174-183.
5. Karpman D., Adreasson A., Thysell H., Kaplan B.S., Svanborg C. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediat Nephrol 1995, 9:694-699.
6. López E.L., Contrini M.M., Devoto S., de Rosa M.F., Graña M.G., Genero M.H., et al. Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr Infect Dis J 1995, 14:594-598.
7. Proulx F., Seidman E.G., Karpman D. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 2001, 50:163-171.
8. Ohara T., Kojio S., Taneike I., Nakagawa S., Gondaira F., Tamura Y., et al. Effects of azithromycin on Shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002, 46:3478-3483.
9. Matussek A., Lauber J., Bergau A., Hansen W., Rohde M., Dittmar K.E., et al. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 2003, 102:1323-1332.
10. Chart H., Law D., Rowe B., Acheson D.W. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. J Clin Pathol 1993, 46:1053-1054.
11. Katagiri Y.U., Mori T., Nakajima H., Katagiri C., Taguchi T., Takeda T., et al. Activation of Src family kinase Yes induced by Shiga toxin binding to globotriaosyl ceramide (/CD77) in low density, detergent-insoluble microdomains. J Biol Chem 1999, 274:35278-35282.
12. Kovbasnjuk O., Edidin M., Donowitz M. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J Cell Sci 2001, 114:4025-4031.
13. Torgersen M.L., Lauvrak S.U., Sandvig K. The A-subunit of surface-bound Shiga toxin stimulates clathrin-dependent uptake of the toxin. FEBS J 2005, 272:4103-4113.
14. Okayama A., Mikasa K., Matsui N., Higashi N., Miyamoto M., Kita E. An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection by use of a combination of phosphodiesterase inhibitors. J Infect Dis 2004, 190:2129-2136.
15. Louise C.B., Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1ß, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 1991, 59:4173-4179.
16. van de Kar Ncaj L., Monnens A.H., Karmali M.A., Van Hinsbergh V.W. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992, 80:2755-2764.
17. Obrig T.G., Louise C.B., Lingwood C.A., Boyd B., Barley-Maloney L., Daniel T.O. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993, 268:15484-15488.
18. Kita E., Yunou Y., Kurioka T., Harada H., Yoshikawa S., Mikasa K., et al. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin producing Escherichia coli O157:H7. Infect Immun 2000, 68:1207-1214.
19. Eisenhauer P.B., Chaturvedi P., Fine R.E., Ritchie A.J., Pober J.S., Cleary T.G., et al. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 2001, 69:1889-1894.
20. Lin G., Bornfeldt K.E. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem Biophys Res Commun 2002, 290:663-669.
21. Falguiéres T., Mallard F., Baron C., Hanau D., Lingwood C., Goud B., et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 2001, 12:2453-2468.
22. Tesh V.L., Samuel J.E., Perera L.P., Sharefkin J.B., O'Brien A.D. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 1991, 164:344-352.
23. Essayan D.M. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001, 108:671-680.
24. Remaley A.T., Neufeld E.B., Brewer H.B. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res 2001, 42:1339-1345.
25. Haidar B., Denis M., Krimbou L., Marcil M., Genest J. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 2002, 43:2087-2094.
26. Haidar B., Denis M., Marcil M., Krimbou L., Genest J. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem 2004, 279:9963-9969.
27. Landry Y.D., Denis M., Nandi S., Bell S., Vaughan A.M., Zha X. ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 2006, 281:36091-36101.
28. Hoey D.E., Sharp L., Currie C., Lingwood C.A., Gally D.L., Smith D.G. Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 2003, 5:85-97.
29. Nichols B. GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr Biol 2003, 13:686-690.
30. Khine A.A., Tam P., Nutikka A., Lingwood C.A. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 2004, 14:701-712.
31. Falguières T., Römer W., Amessou M., Afonso C., Wolf C., Tabet J.C., et al. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J 2006, 273:5205-5218.
32. Mendez A.J., Lin G., Wade D.P., Lawn R.M., Oram J.F. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 2001, 276:3158-3166.
33. Drobnik W., Borsukova H., Bottcher A., Pfeiffer A., Liebisch G., Schutz G.J., et al. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 2002, 3:268-278.
34. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000, 2:399-406.
35. Zha X., Genest J., McPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport. J Biol Chem 2001, 276:39476-39483.
36. Alder-Baerens N., Müller P., Pohl A., Korte T., Hamon Y., Chimini G., et al. Headgroup-specific exposure of phospholipids in ABCA1-expressing cells. J Biol Chem 2005, 280:26321-26329.
37. Römer W., Berland L., Chambon V., Gaus K., Windschiegl B., Tenza D., et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007, 450:670-675.
38. Römer W., Pontani L.L., Sorre B., Rentero C., Berland L., Chambon V., et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis. Cell 2010, 140:540-553.
39. Ilangumaran S., Arni S., van Echten-Deckert G., Borisch B., Hoessli D.C. Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes. Mol Biol Cell 1999, 10:891-905.
40. Yasuda Y., Kasahara K., Mizuno F., Nishi K., Mikasa K., Kita E. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. Antimicrob Agents Chemother 2007, 51:1741-1752.
41. Jung C., Kim R.S., Zhang H.J., Lee S.J., Jeng M.H. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res 2004, 64:9185-9192.
42. Walker J., Bossman P., Lackey B.R., Zimmerman J.K., Dimmick M.A., Hilderman R. The adenosine 5', 5″', P1, P4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry 1993, 50:14009-14014.
43. Chinetti G., Lestavel S., Bocher V., Remaley A.T., Neve B., Torra I.P., et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001, 7:53-58.
44. Yagi H., Narita N., Matsumoto M., Sakurai Y., Ikari H., Yoshioka A., et al. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am J Hematol 2001, 66:105-115.
45. Natarajan N., Shambaugh G.E., Elseth K.M., Haines G.K., Radosevich J.A. Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay. Biotechniques 1994, 17:166-171.